Literature DB >> 22095280

In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.

D M Moujalled1, W D Cook, J M Lluis, N R Khan, A U Ahmed, B A Callus, D L Vaux.   

Abstract

Binding of TNF to TNF receptor-1 can give a pro-survival signal through activation of p65/RelA NF-κB, but also signals cell death. To determine the roles of FLICE-inhibitory protein (FLIP) and caspase-8 in TNF-induced activation of NF-κB and apoptosis, we used mouse embryonic fibroblasts derived from FLIP and caspase-8 gene-deleted mice, and treated them with TNF and a smac-mimetic compound that causes degradation of cellular inhibitor of apoptosis proteins (cIAPs). In cells treated with smac mimetic, TNF and Fas Ligand caused wild-type and FLIP(-/-) MEFs to die, whereas caspase-8(-/-) MEFs survived, indicating that caspase-8 is necessary for death of MEFs triggered by these ligands when IAPs are degraded. By contrast, neither caspase-8 nor FLIP was required for TNF to activate p65/RelA NF-κB, because IκB was degraded, p65 translocated to the nucleus, and an NF-κB reporter gene activated normally in caspase-8(-/-) or FLIP(-/-) MEFs. Reconstitution of FLIP(-/-) MEFs with the FLIP isoforms FLIP-L, FLIP-R, or FLIP-p43 protected these cells from dying when treated with TNF or FasL, whether or not cIAPs were depleted. These results show that in MEFs, caspase-8 is necessary for TNF- and FasL-induced death, and FLIP is needed to prevent it, but neither caspase-8 nor FLIP is required for TNF to activate NF-κB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095280      PMCID: PMC3321619          DOI: 10.1038/cdd.2011.151

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.

Authors:  T Kataoka; R C Budd; N Holler; M Thome; F Martinon; M Irmler; K Burns; M Hahne; N Kennedy; M Kovacsovics; J Tschopp
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

2.  c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis.

Authors:  David W Chang; Zheng Xing; Yi Pan; Alicia Algeciras-Schimnich; Bryan C Barnhart; Shoshanit Yaish-Ohad; Marcus E Peter; Xiaolu Yang
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

3.  Cytoplasmic p53 is not required for PUMA-induced apoptosis.

Authors:  B A Callus; P G Ekert; J E Heraud; A M Jabbour; A Kotevski; J E Vince; J Silke; D L Vaux
Journal:  Cell Death Differ       Date:  2007-11-09       Impact factor: 15.828

4.  NF-kappaB signals induce the expression of c-FLIP.

Authors:  O Micheau; S Lens; O Gaide; K Alevizopoulos; J Tschopp
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation.

Authors:  A Devin; A Cook; Y Lin; Y Rodriguez; M Kelliher; Z Liu
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

6.  Activation of the NF-kappaB pathway by caspase 8 and its homologs.

Authors:  P M Chaudhary; M T Eby; A Jasmin; A Kumar; L Liu; L Hood
Journal:  Oncogene       Date:  2000-09-14       Impact factor: 9.867

7.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.

Authors:  E E Varfolomeev; M Schuchmann; V Luria; N Chiannilkulchai; J S Beckmann; I L Mett; D Rebrikov; V M Brodianski; O C Kemper; O Kollet; T Lapidot; D Soffer; T Sobe; K B Avraham; T Goncharov; H Holtmann; P Lonai; D Wallach
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

8.  FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.

Authors:  T Kataoka; M Schröter; M Hahne; P Schneider; M Irmler; M Thome; C J Froelich; J Tschopp
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

9.  N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway.

Authors:  Takao Kataoka; Jürg Tschopp
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 10.  IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.

Authors:  Mads Gyrd-Hansen; Pascal Meier
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

View more
  10 in total

1.  Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion.

Authors:  S A Conos; K E Lawlor; D L Vaux; J E Vince; L M Lindqvist
Journal:  Cell Death Differ       Date:  2016-07-15       Impact factor: 15.828

2.  Mitochondria targeting of non-peroxidizable triphenylphosphonium conjugated oleic acid protects mouse embryonic cells against apoptosis: role of cardiolipin remodeling.

Authors:  Yulia Y Tyurina; Muhammad A Tungekar; Mi-Yeon Jung; Vladimir A Tyurin; Joel S Greenberger; Detcho A Stoyanovsky; Valerian E Kagan
Journal:  FEBS Lett       Date:  2011-12-28       Impact factor: 4.124

3.  N-(3-Oxo-acyl)-homoserine lactone induces apoptosis primarily through a mitochondrial pathway in fibroblasts.

Authors:  Aaron M Neely; Guoping Zhao; Christian Schwarzer; Nicole S Stivers; Aaron G Whitt; Shuhan Meng; Joseph A Burlison; Terry E Machen; Chi Li
Journal:  Cell Microbiol       Date:  2017-10-09       Impact factor: 3.715

4.  RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.

Authors:  Nozomi Takahashi; Lars Vereecke; Mathieu J M Bertrand; Linde Duprez; Scott B Berger; Tatyana Divert; Amanda Gonçalves; Mozes Sze; Barbara Gilbert; Stephanie Kourula; Vera Goossens; Sylvie Lefebvre; Claudia Günther; Christoph Becker; John Bertin; Peter J Gough; Wim Declercq; Geert van Loo; Peter Vandenabeele
Journal:  Nature       Date:  2014-09-04       Impact factor: 49.962

5.  Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells.

Authors:  Sher Zaman Safi; Laiba Saeed; Humaira Shah; Zahina Latif; Abid Ali; Muhammad Imran; Nawshad Muhammad; Talha Bin Emran; Vetriselvan Subramaniyan; Ikram Shah Bin Ismail
Journal:  Mol Biol Rep       Date:  2022-08-04       Impact factor: 2.742

6.  X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.

Authors:  Iyabode O Ajayi; Thomas H Sisson; Peter D R Higgins; Adam J Booth; Rommel L Sagana; Steven K Huang; Eric S White; Jessie E King; Bethany B Moore; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

7.  Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio/chemo-sensitivity.

Authors:  Ruru Wang; Yajing Shang; Bin Chen; Feng Xu; Jie Zhang; Zhaoyang Zhang; Xipeng Zhao; Xiangbo Wan; An Xu; Lijun Wu; Guoping Zhao
Journal:  Cell Death Dis       Date:  2022-10-06       Impact factor: 9.685

8.  TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1.

Authors:  D M Moujalled; W D Cook; T Okamoto; J Murphy; K E Lawlor; J E Vince; D L Vaux
Journal:  Cell Death Dis       Date:  2013-01-17       Impact factor: 8.469

9.  Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling.

Authors:  Barbara Valentinis; Simona Porcellini; Claudia Asperti; Manuela Cota; Dan Zhou; Paola Di Matteo; Gianpiero Garau; Chiara Zucchelli; Nilla Roberta Avanzi; Gian Paolo Rizzardi; Massimo Degano; Giovanna Musco; Catia Traversari
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

10.  Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.

Authors:  Vasilisa Aksenova; Lidia Turoverova; Mikhail Khotin; Karl-Eric Magnusson; Eugene Tulchinsky; Gerry Melino; George P Pinaev; Nickolai Barlev; Dmitri Tentler
Journal:  Oncotarget       Date:  2013-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.